Skip to Main Content
Table 3

Adverse events

Dasiglucagon (n = 82)Placebo (n = 43)Glucagon (n = 43)
All adverse events 66 (80) 14 (33) 32 (74) 
Drug-related* adverse events 52 (63) 3 (7) 27 (63) 
Most commonly reported drug-related* adverse events    
 Nausea 45 (55) 1 (2) 23 (53) 
 Vomiting 19 (23) 1 (2) 9 (21) 
 Headache 8 (10) 1 (2) 4 (9) 
 Injection site erythema 1 (1) 2 (5) 2 (5) 
Dasiglucagon (n = 82)Placebo (n = 43)Glucagon (n = 43)
All adverse events 66 (80) 14 (33) 32 (74) 
Drug-related* adverse events 52 (63) 3 (7) 27 (63) 
Most commonly reported drug-related* adverse events    
 Nausea 45 (55) 1 (2) 23 (53) 
 Vomiting 19 (23) 1 (2) 9 (21) 
 Headache 8 (10) 1 (2) 4 (9) 
 Injection site erythema 1 (1) 2 (5) 2 (5) 

Data are n (%).

*

Possibly or probably drug-related adverse events, as reported by the investigator.

Occurring in ≥5% of participants in any treatment group.

Close Modal

or Create an Account

Close Modal
Close Modal